Showing results (1861-1870 of 2,335) with videos related to
Sort By:
Pageof 234
American Journal of Public Health|June 8, 2001
Gonorrhea in the HIV era: a reversal in trends among men who have sex with menK K Fox, C del Rio, K K Holmes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignanciesUdai Banerji, Anne O'Donnell, Michelle Scurr, et al.Cancer Research Communications|July 17, 2025
Assessing MC1R Variants in Lentigo Maligna Melanoma within the Utah PopulationAmanda Jiang, Annabelle Huntsman, Carly Becker, et al.The Gerontologist|June 27, 2025
Beyond "worried well": health care professionals' perspectives on improving subjective cognitive decline careRyan A Mace, Mason J Stewart-McLellan, Makenna E Law, et al.Alcoholism, Clinical and Experimental Research|July 24, 2019
Mechanisms of Persistent Neurobiological Changes Following Adolescent Alcohol Exposure: NADIA Consortium FindingsFulton T Crews, Donita L Robinson, L Judson Chandler, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 28, 2023
Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosisRebecca Klein, Marc Judson, Briana Barkes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies GroupE Briasoulis, I Judson, N Pavlidis, et al.Respiratory Medicine|April 22, 2017
The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosisAlbert Huho, Llewellyn Foulke, Timothy Jennings, et al.Lancet (London, England)|September 29, 2004
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialJaap Verweij, Paolo G Casali, John Zalcberg, et al.British Journal of Cancer|September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursM J A de Jonge, S Kaye, J Verweij, et al.Pageof 234